Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Packer M, Anker SD, Butler J, et al.
N Engl J Med. Pub. online 29 August 2020
Leggi
Management of metabolic adverse events of targeted therapies and immune checkpoint inhibitors in cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper
Silvestris N, Argentiero A, Beretta G, Di Bartolo P, Montagnani M, Danesi R, Ferrari P, D’Oronzo S, Gori S, Russo A, Acquati S, Gallo M
Crit Rev Oncol Hematol. 2020;154:103066
Leggi
Presentazione nuovi dati Annali AMD 2018
Carissime Socie, carissimi Soci, siamo lieti di annunciare l’evento di presentazione dei nuovi dati Annali AMD. L’ultima raccolta dati, relativa all’anno 2018, ha evidenziato un ulteriore incremento dei centri coinvolti registrando il coinvolgimento di 258 strutture di diabetologia per un totale di oltre 500.000 persone con diabete. Il volume in…
Leggi
Need for less tight glucose control in early pregnancy after embryogenesis due to high risk of maternal hypoglycaemia in women with pre‐existing diabetes can be compensated by good control in late pregnancy
Hauffe F,Fauzan R, Schohe AL, et al.
Diabetic Medicine. Pub. online 2 August 2020
Leggi
Assessment of the effect of the COVID‐19 lockdown on glycaemic control in people with type 1 diabetes using flash glucose monitoring
Dover AR, Ritchie SA, McKnight JA, et al.
Diabetic Medicine. Pub. online 2 August 2020
Leggi
COVID-19 in people with diabetes: understanding the reasons for worse outcomes
Apicella M, Campopiano MC, Mantuano M, et al.
The Lancet Diabetes & Endocrinology. Pub. online 17 July 2020
Leggi
Comparison of the FreeStyle Libre Pro Flash Continuous Glucose Monitoring (CGM) system and Point-of-Care Capillary Glucose Testing (POC) in hospitalized patients with Type 2 Diabetes (T2D) treated with basal-bolus insulin regimen
Galindo RJ, Migdal AL, Davis GM, et al.
Diabetes Care. 202;dc192073
Leggi
Pregravid HbA1c and glucose measurement to rule out future gestational diabetes mellitus and reduce the need for oral glucose tolerance testing in pregnancy
Retnakaran R, Shah BR
Diabetes Care. 2020;43(8):e93-e95
Leggi
Is coronary artery disease inevitable in type 2 diabetes? From a glucocentric to a holistic view on patient management
Ferrannini G, Norhammar A, Gyberg V, et al.
Diabetes Care. 2020 Jul; 13;dci200002.
Leggi